Limited-time offer
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
One drug firm received fees over €225m from the HSE through the executive’s High Tech Drugs and Medicines scheme in 2014, new figures show.
Fri, 01 Apr, 2016
News
Friday, March 27, 2026 - 9:00 PM
Friday, March 27, 2026 - 8:00 PM